Actively Recruiting
Validation of Sensors for Long-term Non-Invasive Fetal Monitoring
Led by University of Manchester · Updated on 2025-05-01
69
Participants Needed
1
Research Sites
82 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A multidisciplinary team of a doctor and engineers have developed a new sensor that will be able to detect mothers' and babies' heartbeat and babies movements in late pregnancy. This sensor can be placed in contact with the mothers' skin over the pregnant uterus without having to be stuck down. We anticipate that this sensor would allow us to monitor babies for longer periods of time which might help us to better identify babies who are being deprived of oxygen during pregnancy. We need to test these sensors on women in late pregnancy for two reasons. Firstly, we need to ensure they reliably measure mother and babies heart rates without interference from movement or other electrical equipment. Secondly we need to ensure that the information they provide is accurate (compared to current measurement techniques). We will carry out two related studies. The first will include up to 24 women to develop the sensors to ensure that they can obtain consistent signals from mothers' and babies' heartbeats without interference from movement and other electronic devices. We will adjust the electronics in the sensors to ensure they give the best signal. The second will include up to 45 women to see whether the information detected by the sensors is comparable to existing technologies. This information will help us to see whether these sensors can be organised into a new device for fetal monitoring which can then be tested.
CONDITIONS
Official Title
Validation of Sensors for Long-term Non-Invasive Fetal Monitoring
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Non-anomalous singleton pregnancy after 28 weeks' gestation
- Estimated fetal weight between 10th and 90th percentile
- Participant is 16 years or older and can give independent consent
You will not qualify if you...
- Presence of fetal anomalies as defined by NHS Fetal Anomaly Screening Programme
- Multiple pregnancy (twins or more)
- Evidence of fetal growth restriction (estimated fetal weight below 10th percentile)
- Inability to speak or understand fluent English
- Participants unable to give informed consent
- Age under 16 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Manchester University NHS Foundation Trust
Manchester, United Kingdom, M13 9WL
Actively Recruiting
Research Team
A
Alexander Heazell, PhD
CONTACT
E
Emma Tomlinson, RM
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here